Laser zaps NF1 skin bumps in small trial
NCT ID NCT06934928
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether monthly alexandrite laser treatments can safely shrink or improve the look of skin tumors in adults with neurofibromatosis type 1 (NF1). Ten participants will receive up to six monthly laser sessions, with some areas treated with cooling and others without. The main goals are to check for side effects and see if tumors shrink by more than half.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Alexandrite laser (755 nm) with skin cooling
- What this could lead to
- If it works, this could offer a non-surgical option to shrink or improve the appearance of skin tumors in people with NF1.
- What could go wrong
- This is a very small, early-stage trial (10 people) that is currently suspended. It only tests safety and tumor appearance, not long-term outcomes. Skin reactions or pain may occur.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROFIBROMATOSIS 1 (NF1) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Wellman Center for Photomedicine, Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.